Herbalife is expanding its personal nutritional supplement capabilities through the planned acquisition of Bioniq

Transaction accelerates Herbalife and Cristiano Ronaldo’s commitment to scale personalized nutrition and wellness worldwide

LOS ANGELES–( BUSINESS WIRE )– Herbalife Ltd. (NYSE: HLF), a leading health and wellness company, community and platform, today announced an agreement to acquire certain assets from Bioniq, a UK-based personal supplements company focused on making health accessible and actionable. The deal furthers Herbalife’s vision to become a technology-enabled, data-driven health and wellness platform.

This press release contains multimedia features. Watch the full release here: https://www.businesswire.com/news/home/20260326423343/en/

“The future of health and wellness is becoming more personalized and informed by data,” said Stephen Graziani, CEO of Herbalife. “By combining Bioniq’s personal supplement technology with the strength of Pro2col and our global distributor network, we are expanding our ability to deliver personalized wellness on a global scale.”

Bionic creates personalized supplement formulas using its patented product personalization engine, an individual’s health background, and a proprietary database of biomarkers. Bionic’s personalized supplement formulas are designed for a wide range of individuals, from everyday health consumers to elite athletes, including Cristiano Ronaldo.

Bioniq will complement Herbalife’s previous acquisitions of Pro2col and Link BioSciences to enable Herbalife to offer a broad range of personalized nutritional supplements in multiple delivery formats. Combining Bionic’s offering with Herbalife’s global manufacturing expertise will enable the company to expand personalized nutrition at scale and speed.

“I founded Bionic in 2019 to help people improve their well-being through a science-driven approach to nutrition that incorporates biomarker and lifestyle data,” said Bionic founder and CEO Vadim Fedotov. “I am excited to join Herbalife’s global distributor network and commit to advancing wellness at scale.”

As a long-time global nutrition partner of Herbalife and Bioniq, Cristiano Ronaldo shares Herbalife’s vision to accelerate the availability of personalized nutritional supplements at scale through its global distributor network.

Cristiano Ronaldo said: “Throughout my career, biometrics and personalized nutrition have been central to helping me perform and compete at my highest level. As a long-time Herbalife and Bioniq user, I have experienced first-hand how a proper approach to nutrition can help improve performance.” “I am delighted that Bionic Personal Supplements has become part of Herbalife’s expanding reach of nutritional supplements, helping people take a more informed approach to their health, well-being and performance.”

The transaction is expected to close in the second quarter of 2026, subject to customary closing conditions and regulatory approvals. The $55 million purchase price will be paid over five years, including an initial payment of $10 million at the end of the term. In addition, the transaction value includes contingent payments of up to $95 million based on future performance.

As part of the transaction, Herbalife also received a call option to acquire Bioniq LAB, a standalone platform focused on small molecules and peptides. The call option provides Herbalife with the strategic flexibility to evaluate potential long-term opportunities in this area in a disciplined and capital-efficient manner.

Bioniq personal nutritional supplements are expected to be offered later this year to customers in select countries in Europe and the United States through independent Herbalife distributors, with additional markets to follow.

For more information, visit www.herbalife.com.

About Herbalife Ltd

Herbalife (NYSE: HLF) is a leading health and wellness company, community and platform that has been changing people’s lives since 1980 with superior nutritional products and business opportunity for its independent distributors. The company offers science-backed products to consumers through franchised distributors in more than 90 markets who provide one-on-one support to their customers. A healthier, more active lifestyle to live your best life.

For more information, visit https://ir.herbalife.com.

About Bioniq

Bioniq, launched in 2019 in London, UK, is an industry leader in recommending personalized supplements based on personal questionnaires and blood test data. Shipping globally and utilizing one of the largest personalized nutrition databases, Bionic has created unique formulas for hundreds of thousands of users that incorporate ingredients and dosages tailored to each individual’s nutritional deficiencies.

For more information, visit: https://www.bioniq.com/.

Visible Statements

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact are “preventive statements” for purposes of federal and state securities laws, including estimates of earnings, revenue or other financial items; Any statements of plans, strategies and management objectives, including for future operations, capital expenditures, or share repurchases; any statements about proposed new products, services, or promotions; any statements about future economic conditions or performance; any expression of belief or expectation; and any forward-looking statements under the foregoing or other future events. Forward-looking statements may include, among others, words such as “may”, “will”, “estimate”, “intend”, “continue”, “believe”, “anticipate”, “anticipate” or other similar words.

Although we believe that the expectations reflected in any of our forward-looking statements are reasonable, actual results or outcomes may differ materially from those anticipated or anticipated in our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and subject to risks and uncertainties, many of which are beyond our control. Important factors that could cause our actual results, performance and achievements, or industry results to differ materially from the estimates or projections contained in or implied by our forward-looking statements:

• the potential impact of current global economic conditions, including inflation, unfavorable foreign exchange rate fluctuations, and tariffs or tariffs, on us; our members, customers, and supply chain; and the world economy;

• ability to attract and retain members;

• Our relationship with our members, and our ability to influence the actions of our members;

• Our failure to comply with, or improper conduct by, our employees or members in violation of applicable US and foreign laws, rules and regulations;

• adverse publicity associated with our company or the direct selling industry, including our ability to provide relief to the marketplace and regulators regarding our compliance with applicable laws;

• Changing consumer preferences and demands and improving industry standards, including respect for climate change, sustainability, and other environmental, social and governance issues;

• the competitive nature of our business and industry;

• Legal and regulatory matters, including regulatory actions, or legal challenges related to our products or network marketing program and product liability claims;

• A consent order entered into with the Federal Trade Commission or the FTC, its effect and any failure to comply therewith;

• risks associated with operations internationally and in China;

• our ability to execute growth and other strategic initiatives (such as restructuring efforts, increasing market penetration in existing markets, and personal product and related technology innovations);

• Effectiveness and adoption of new technology-driven initiatives;

• Any material disruption to our business caused by natural disasters, other catastrophic events, acts of war or terrorism, including wars in Ukraine and the Middle East, cyber security incidents, pandemics, and/or other acts by third parties;

• our ability to source and manufacture and distribute ingredients, packaging materials and other raw materials;

• our reliance on our information technology infrastructure, and our ability to successfully develop, deploy and integrate artificial intelligence into our business;

• Violation of privacy, artificial intelligence and data protection laws, rules, regulations or any security by us or our members involving misappropriation, loss or other unauthorized use or disclosure of confidential information; no obedience;

• contractual restrictions on our ability to expand or change our direct sales business model;

• adequacy of our trademarks and other intellectual property;

• product concentration;

• our dependence, or the loss or departure of any member of our senior management team;

• the ability to integrate and invest in acquisition transactions;

• restrictions imposed by the covenants on the management of our debt;

• risks related to our convertible notes;

• changes in, and uncertainty regarding, transfer pricing, income taxes, customs duties, value-added taxes, and other taxation laws, treaties and regulations, or their interpretation;

• our incorporation under the laws of the Cayman Islands; and

• Volatility in share prices with, among other things, speculative trading and certain traders shorting our common shares.

Additional factors and uncertainties that could cause actual results or outcomes to differ materially from our forward-looking statements are described in the company’s filings with the Securities and Exchange Commission, including its annual report on Form 10-K for the fiscal year ended December 31, 2025, filed with the Securities and Exchange Commission on February 26, 2026. “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and included in our consolidated financial statements and related notes. In addition, historical, current, and forward-looking sustainability-related statements may be based on performance measurement standards that are still evolving, internal controls and processes that are evolving, and assumptions that are subject to change in the future.

The statements presented in this publication speak only as of the date. We undertake no obligation to report any events or conditions or to update or release any revisions to the forward-looking statement after that date to reflect the occurrence of unanticipated events, except as required by law.

See the source version at businesswire.com: https://www.businesswire.com/news/home/20260326423343/en/

Media Contact:

Miguel Lopez-Najera

Director of Global Corporate Communications

migueellope@herbalife.com

Investor Relations:

Erin Banias

Vice President, Head of Investor Relations

erinba@herbalife.com

Source: Herbalife Ltd.

Published March 26, 2026 • 6:30am EDT